Esophageal Cancers Active Not Recruiting Phase 1 Trials for Gemcitabine (DB00441)

Also known as: Esophageal cancer / Ca esophagus NOS / Ca esophagus / Malignant neoplasm of esophagus, unspecified / Malignant neoplasm of oesophagus, unspecified / Oesophageal neoplasms malignant / Ca oesophagus / Malignant neoplasm of esophagus / Esophageal cancer NOS / Oesophageal cancer NOS / Oesophageal cancer / Malignant neoplasm of oesophagus / Malignant neoplasm of esophagus NOS / Malignant neoplasm of oesophagus NOS / Cancer of Esophagus / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma

IndicationStatusPhase
DBCOND0045726 (Esophageal Cancers)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02574663TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid TumorsTreatment